EUCTR2008-000106-37-DE进行中（未招募）不适用
Studies on the combined treatment using etanercept and ultraviolet B for patients with moderate to severe psoriasis vulgaris
Klinik für Dermatologie und Allergologie der RUB, St. Josef Hospital0 个研究点开始时间: 2008年5月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Patients eligible for etanercept treatment according to SPC and local guidelines and
- •regulations
- •- Patients ages 18 or older
- •-Psoriasis vulgaris (Plaque-Typ)
- •-given indication of therapy with Etanercept
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Pregnancy or nursing mothers
- •-Patients with severe cardio-respiratory insufficiency
- •-known photodermatosis (for example: urticaria solaris)
- •-known genodermatosis with increased UV-sensitivity
- •-intake of photosensitizing drugs
- •-allergy to local anesthetics
- •-anamnesis of wound healing disorders or keloids
- •-skin cancer in the presence or in the past
- •-systemic immunsuppressive therapy
- •- significant UV-exposure 3 months before the beginning of the study
研究者
相似试验
尚未招募
4 期
Prospective study on the effects of etanercept treatment in patients with rheumatoid arthritis who are naive for TNF-alpha blocking therapy or are non-responders to prior treatment with other anti-TNF-alpha medicatio1000381610023213rheumatoid arthritisNL-OMON32681Academisch Medisch Centrum200
进行中（未招募）
不适用
Prospective study on the effects of etanercept treatment in patients with rheumatoid arthritis who are naïve for TNF-alpha blocking therapy and patients who do not respond (anymore) to prior treatment with other anti-TNF-alpha medication - Not applicablerheumatoid arthritisMedDRA version: 12.0Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2009-015653-20-NL
进行中（未招募）
1 期
A multi-centre randomised trial of Etanercept and Methotrexate to induce remission in early inflammatory arthritis resistent to corticosteroid challenge: The EMPIRE trial - EMPIREEUCTR2005-005467-29-GBniversity of Leeds110
招募中
不适用
Clinical Efficacy of Etanercept in Patients with Rheumatoid Arthritis and its Associated DiseasesRheumatoid arthritisJPRN-UMIN000013368Osaka Medical College30
已完成
3 期
Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisPsoriatic ArthritisNCT02376790Amgen851